Moneycontrol PRO

business

Taro reports stellar Q3; Sun Pharma could see upside

We could expect some amount of further upside coming in for Sun Pharmaceutical Industries because of Taro that reported a very strong set of numbers for Q3 FY14.

first published: Feb 11, 2014 09:26 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347